Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy
There is a significant unmet need for therapeutics to treat ocular surface barrier damage, also called epitheliopathy, due to dry eye and related diseases. We recently reported that the natural tear glycoprotein CLU (clusterin), a molecular chaperone and matrix metalloproteinase inhibitor, seals and...
Main Authors: | Shravan K. Chintala, Jinhong Pan, Sandeep Satapathy, Rebecca Condruti, Zixuan Hao, Pei-wen Liu, Christian F. O’Conner, Joseph T. Barr, Mark R. Wilson, Shinwu Jeong, M. Elizabeth Fini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/2/981 |
Similar Items
-
Clusterin in cancer: Dual role as a tumor suppressor gene and an oncogene
by: Rajashree Kadam, et al.
Published: (2016-01-01) -
Natural Course of Pachychoroid Pigment Epitheliopathy
by: Mariko Yagi, MD, et al.
Published: (2022-12-01) -
The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process
by: Chiara Lenzi, et al.
Published: (2020-09-01) -
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
by: Abigail K. Elias, et al.
Published: (2022-10-01) -
Immunohistochemical expression of clusterin in colorectal carcinoma
by: Jalal Ali Jalal, et al.
Published: (2021-08-01)